Ibm Retirement Fund United Therapeutics Corp Transaction History

Ibm Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$184.32 - $216.08 $229,478 - $269,019	-1,245 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$170.47 - $211.93 $40,571 - $50,439	-238 Reduced 16.05%	1,245 $223,000
Q1 2021 Apr 22, 2021	SELL	$153.94 - $174.85 $20,166 - $22,905	-131 Reduced 8.12%	1,483 $248,000
Q4 2020 Jan 25, 2021	BUY	$101.87 - $151.79 $164,418 - $244,989	1,614 New	1,614 $245,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.